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The effect of oral creatine (Cr) supplementation with 20 g/ day for 7 days on one-hour 
cycling performance and metabolism was investigated in a double-blind placebo 
controlled study. Twenty endurance-trained male cyclists volunteered for the study that 
was approved by the University of Cape Town ethics committee. The subjects' peak 
sustained power output was measured and they underwent a familiarization one-hour 
cycle on a cycle ergometer. Five days later subjects had a muscle biopsy and an in-
dwelling cannula was inserted into a forearm vein before performing a maximal one-hour 
cycle (Tl) during which blood samples were taken at regular intervals. Following the 
cycle, the subjects each received either Cr or placebo tablets to be ingested four times per 
day for the following week. After the loading week the subjects again reported to the 
laboratory, had a muscle biopsy and underwent and the same test routine (T2) with blood 
sampling as the previous week. Resting muscle total Cr measured by HPLC increased 
significantly (p<0.001) in the Cr group from 123.0 ± 3.8 mmol/ kg dry wt to 159.8 ± 7.9 
mmol/ kg dry wt, but was unchanged in the placebo group. The extent of Cr loading was 
not related to baseline Cr levels (r=0.46, NS). No differences were noted in the resting 
levels of adenine nucleotides in either group. Analyses of the plasma samples indicated 
no change in plasma lactate concentration, but a significant lowering of indicators of 
adenine nucleotide degradation including concentrations of plasma ammonia (p<0.05) 
and hypoxanthine (p<0.01) in the Cr group from Tl to T2. Plasma urate concentration 
was significantly lowered (p<0.01) from Tl to T2 but there were no differences between 
groups. Cr supplementation did not significantly improve performance in the one-hour 
trial (Cr group: 39.1 ± 0.9 km vs 39.8 ± 0.8 km and placebo group: 39.3 ± 0.8 km vs 
39.2 ± 1.1 km). We hypothesised that Cr supplementation affects the purine nucleotide 
cycle through improved maintenance of low intracellular ADP during exercise as a result 
of enhanced efficiency of the Cr-PCr shuttle. Cr supplementation had no effect on lactate 
and carbohydrate metabolism and did not improve performance significantly during a 
one-hour cycle trial. 
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CHAPTER 1: RATIONALE AND AIMS 
Supplementing human diets with creatine (Cr) is not a new concept. Studies by Crim et al., (1976) 
have examined the size of the body Cr pool and its effect on Cr turnover through supplementation 
procedures combined with radioactive tracer labeling techniques. In addition, the effect of oral Cr 
supplementation has been studied in patients with a Cr deficiency such as those with gyrate 
atrophy of the choroid and retina (Sipila et al., 1981). However, it is only in recent years that 
several groups have examined the effect of Cr supplementation on muscle Cr content and athletic 
performance. 
The role that Cr in its phosphorylated form, phosphocreatine (PCr), plays in the body is primarily 
one of an 'energy reservoir' to regenerate adenosine triphosphate (ATP) which has been 
hydrolysed to adenosine diphosphate (ADP). It is not surprising that most of the body's PCr is 
found in muscle, since the rate of ATP turnover in this tissue is greatly increased by exercise. The 
rapid regeneration of ATP in muscle by PCr hydrolysis during exercise prevents reductions in the 
ATP:ADP ratio that would otherwise decrease the transfer of free energy to the myosin heads of 
the thick myofilaments in the myofibrils. ATP regeneration by nett PCr hydrolysis is particularly 
important during intense, maximal activity when ATP turnover is at its highest. 
Therefore the first studies examined the effects of additional Cr ingestion on exercise performance 
in maximal exercise or on several intermittent bouts of maximal or near maximal exercise. Some of 
these studies showed performance enhancement (Balsom et al., 1993a; Birch et al., 1994; Earnest 
et al., 1994 (Abstract); Greenhaff et al., 1993a; Lemon et al., 1995 (Abstract); Soderlund et al., 
1994 (Abstract); Viru and Nurmeviki, 1993) and others failed to show any improvements (Almada 
et al., 1995 (Abstract); Balsom et al., 1993b; Burke et al., 1995 (Abstract); Cooke et al., 1995; 
Grindstaff et al., 1995 (Abstract); Odland et al., 1994 (Abstract); Redondo et al., 1995 (Abstract); 
Stroud et al., 1994). It is unknown whether these negative results were due to poor uptake of the 
ingested creatine, since individual responses to creatine loading are variable (Harris et al., 1992; 
Lemon et al., 1995 (Abstract)). Teleologically it would make more sense for a sprinter who 
utilises the phosphagen energy system to a much greater extent than an endurance athlete, to have 
higher muscle TCr. Spriet (1995) summarised data showing that PCr content of Type II fibres to 
be 5 - 15 % higher than in Type I fibres. Therefore, if endurance athletes have more Type I fibres 
than sprinters, their baseline PCr content may also be different. Since Harris et al., ( 1992) have 
shown that low baseline levels enhance muscle Cr uptake during supplementation, endurance 
athletes may have a greater retention of the Cr supplement than previously shown in more 
generally active subjects. This however has not been determined since few studies have been 
performed on endurance athletes and Cr supplementation, and none of these have performed 
muscle biopsies for determination of muscle Cr concentration. 
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In some of these studies, the authors also investigated the effects of Cr supplementation on 
metabolic changes associated with fatigue during exercise (Balsom et al., 1993a; Balsom et al., 
1993b; Birch et al., 1994; Greenhaff et al., 1993a; Stroud et al., 1994; Soderlund et al., 1994 
(Abstract)). Results indicated that plasma ammonia (NH3) levels were lowered (Birch et al., 1994; 
Greenhaff et al., 1993a) and plasma hypoxanthine (Hx) levels were lowered (Balsom et al., 1993a) 
or unchanged (Balsom et al., 1993b) as a result of Cr loading. However, plasma lactate was 
lowered in two studies (Balsom et al., 1993a; Soderlund et al., 1994 (Abstract)), but not in others 
(Balsom et al., 1993b; Birch et al., 1994; Greenhaff et al., 1993a; Stroud et al., 1994). Evidently 
Cr supplementation is in some way altering metabolism during exercise and the paradigm arising 
from the initial studies is that the main effect of Cr supplementation is to reduce adenine 
nucleotide degradation during high intensity, maximal or near maximal exercise. 
The fact that two studies have shown decreases in plasma lactate with Cr loading implies that 
increased muscle PCr levels may influence carbohydrate (CHO) metabolism as well. This may be 
related to the duration of the exercise. In addition, Cr may play a role in the regulation of the rate 
of mitochondrial ATP production (Jacobus, 1985; Korge and Campbell, 1995; Radda et al., 1995). 
If CHO metabolism and mitochondrial function are altered through Cr supplementation, it is 
possible that exercise performance at submaximal intensities may also be influenced. Evidence in 
support of an effect of Cr concentration on mitochondria is given by the enhanced rate of PCr 
rephosphorylation during rest after Cr supplementation (Greenhaff et al., 1993b ). 
Several studies not examining the effects of Cr supplementation have shown appreciable ammonia 
(Bouckaert and Pannier, 1995; Brouns et al., 1990) and lactate accumulation (Palmer et 
al.,unpublished data) during endurance exercise lasting approximately one hour. There is also 
substantial evidence that high ammonia accumulation is often accompanied by high lactate 
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accumulation (Bouckaert and Pannier, 1995; Urhausen and Kindermann, 1992). It is thought that 
as Cr has been shown to have an effect on these measures during maximal exercise, there may be a 
similar effect in high intensity submaximal exercise. Thus, should PCr rephosphorylation also be 
enhanced during submaximal exercise, a role for Cr supplementation for endurance athletes may 
be warranted in terms of alterations in adenine nucleotide and carbohydrate metabolism possibly 
translating into improved performance. This is thought to be via the increase in PCr lowering the 
accumulation of adenosine diphosphate (ADP), adenosine monophosphate (AMP), ammonia and 
inosine monophosphate(IMP). These compounds are all participants in adenine nucleotide 
metabolism and are also allosteric activators of glycolytic activity. Therefore a lessening in the 
accumulation of these products will affect both adenine nucleotide and carbohydrate metabolism, 
indicated in lower levels of plasma ammonia and blood lactate. Thus, it needs to be investigated 
whether the effects seen in adenine nucleotide and carbohydrate metabolism during maximal 
exercise are also evident in high-intensity submaximal exercise where similar systems of energy 
provision are affected but to a lesser degree. 
It should be noted, however, that the use of PCr as a fuel substrate is not limiting during 
endurance exercise since the rate of ATP demand is not high enough. Thus, in endurance exercise, 
the role of Cr as an ergogenic aid either would be as a 'high energy' phosphate carrier or by 
improving the efficiency of 'high energy' transfer from ATP to Cr at the mitochondrial membrane 
and from PCr to ADP at the myofibrils. This may alter metabolism sufficiently to decrease some 
factors related to fatigue which are not related to substrate availability, for example, ADP and Pi 
concentrations. Perception of relative fatigue during sustained high intensity exercise (as opposed 
to perception of fatigue sufficient to halt exercise completely) is likely to influence the chosen gear 
ratios and pace, both of which may influence the specific exercise task utilised in this study. 
Accordingly, the aims of this study were to examine the effect of oral creatine supplementation on 
i) muscle creatine content in well-trained endurance athletes, ii) high-intensity endurance exercise 
performance during a cycling distance trial lasting one-hour and iii) adenine nucleotide and 
carbohydrate metabolism during the cycling trial and recovery. 
CHAPTER 2: INTRODUCTION 
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CHAPTER 2: INTRODUCTION 
2.1 THE ENERGY SYSTEMS UTILISED DURING EXERCISE 
Muscular contraction is an energy requiring process which involves the interaction between the 
thick and thin filaments (the contractile proteins) that constitute a muscle fibre (McArdle et al., 
1991). This involves the hydrolysis of ATP to ADP with the subsequent release of phosphate (Pi), 
ADP and free energy. The latter is utilised for the conformational changes in myosin that result in 
force production (Cooke, 1986). In order to provide energy for muscular activity various 
metabolic pathways that resynthesise ATP from ADP are activated. It is important to maintain an 
optimal ATP concentration as well as a high ATP:ADP ratio in order for contraction to continue. 
These metabolic pathways are activated to varying degrees depending on both the intensity and 
duration of the exercise bout (Astrand and Rodahl, 1970; Hawley and Hopkins, 1995). These 
pathways or energy systems include the phosphagen (ATP and PCr hydrolysis) system, oxygen-
(02) independent glycolysis, 02-dependent CHO oxidation, 02-dependent lipid oxidation and to 
some extent protein oxidation (Hawley and Hopkins, 1995). In addition, another system called the 
purine nucleotide cycle (PNC) may be activated (Tullson and Terjung, 1991). The major function 
of this system is not to produce ATP, but rather to remove excess ADP in order to maintain an 
optimal ATP:ADP ratio. 
2.1.1 THE PHOSPHAGEN SYSTEM 
This system stores energy in the form of 'high energy' phosphate bonds and this energy can be 
liberated by hydrolysis conformational change and product release. Myosin ATPase hydrolyses 
ATP to ADP and Pi. The free energy released at pH 7 is high, -7.3 kcal/ mol (Stryer, 1995). A 
'high energy' phosphate bond also exists between Cr and Pi when it is present as the phosphagen 
PCr. PCr hydrolysis itself releases -10.3 kcal/ mol of free energy (Stryer, 1995). PCr is used for 
immediate resynthesis of ADP to ATP through a 'high-energy' phosphate transfer reaction 
catalysed by a myofibrillar creatine kinase (CK). Approximately 60 to 66.8% of the total Cr (TCr) 
exists as PCr in non-working muscles (Harris et al., 1974; Harris et al., 1992). 
Energy demand of muscle contraction results in decreased levels of ATP and increased levels of 
ADP and the equilibrium of the CK reaction then favours ATP formation (Sweeney, 1994). The 
CK reaction operates at high levels of efficiency and does not utilise oxygen. PCr is therefore a 
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major substrate for rapid resynthesis of ATP in the muscle, particularly during very high intensity, 
short duration exercise (McArdle et al., 1991). This is because of the proximity of the CK 
enzymes to the contractile proteins and the ease with which the activity of CK can be increased by 
small decreases in ATP concentrations (Sweeney, 1994). This function of PCr as an immediate 
buffer to energy use is limited by its fairly low concentration. 
Regeneration of the PCr supply is an oxidative process occuring in the mitochondria where a 
different isoform of CK exists than that found at the myofibrils. Thus, CK is found in close 
association with both the contractile proteins of the myofibrils and the mitochondria. Recent 
research has shown that the 'shuttle' has more functions than simply as a buffer to energy use and 
a transport network (Sweeney, 1994; Walliman et al., 1992). It has also been found to be vital in: 
preventing rises in ADP which among other things is a precursor to adenine nucleotide loss, 
preventing increases in hydrogen ion concentrations, indirectly regulating glycogenolysis and 
glycolysis through the release of inorganic phosphate (Pi), regulating the ATP:ADP ratio and as a 
regulator of mitochondrial respiration. For these reasons Walliman et al., (1992) suggest that the 
'Cr-PCr shuttle' be renamed the 'PCr circuit'as this term implies more functions than simply 
transport. 
Several recently published studies (Jacobus, 1985; Thompson et al., 1995; Radda et al., 1995; 
Wilson, 1994; Meyer and Foley, 1994; Walliman et al., 1992) have indicated that these functions 
are the subject of much debate especially in the light of research (Meyer et al., 1986; Wyss and 
Walliman, 1994) on beta-guanadinopropionate ( a Cr analogue) fed rats, which has indicated that 
simple diffusion of ATP is a sufficient energy translocation process under most conditions. This 
probably indicates that the 'shuttle' or 'PCr circuit' is not essential for steady state energy 
production but does seem to be important in regulating glycolytic process through the release of 
phosphate by PCr hydrolysis. The 'shuttle' does seem to provide a far more efficient method of 
energy translocation than by the simple diffusion of ATP. Thus, for the purposes of this 
discussion, the terms 'Cr-PCr shuttle' and 'PCr circuit' will be used interchangeably and both 
should be recognised as having all functions discussed above. 
The absolute intramuscular contents of Cr and PCr are important metabolic regulators of the other 
energy provision pathways. Decreased levels of PCr and increased levels of Cr are two of the 
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important intracellular signals that the ATP demand of the exercise is such that more sustainable 
processes of energy provision are required. Decreased levels of PCr and increased levels of Cr aid 
in the regulation of substrate cycling that occurs during the acceleration of Oi-independent CHO 
metabolism by enhancing the rate of the phosphofructokinase (PFK) reaction as well as glycogen 
phosphorylase activity (as reviewed by Spriet, 1995). This occurs both directly where Cr and PCr 
regulate PFK and glycogen phosphorylase, and indirectly where the Pi liberated from PCr 
hydrolysis also causes activation of these enzymes. Thus, Cr and PCr play a role in regulating 
glycolytic and glycogenolytic activity. Alternatively Cr also aids the aerobic systems through its 
action as a rapid transportation system of 'high-energy' phosphate from the mitochondria (the site 
of aerobic ATP synthesis) to the myofibrils ( the site of ATP use). This reaction is mediated by 
mitochondrially bound CK and ensures that ATP does not accumulate intra-mitochondrially and 
that ADP is always readily available for subsequent oxidative rephosphorylation and is therefore 
indirectly a participant in the regulation of mitochondrial respiration ( as reviewed by Hargreaves, 
1995). Thus, Cr and PCr can be seen important participants in both Di-independent and Oi-
dependent metabolism. 
The relative contribution of this energy yielding process differs not only according to the intensity 
and duration of the exercise, but also the length of rest periods between exercise bouts ( Gaitanos 
et al., 1993; Spencer et al., 1991; Hawley and Hopkins, 1995). The contribution of PCr is 
particularly dependent on the level of its store in the contracting muscle (Harris et al., 1992). The 
free energy released from PCr hydrolysis is sufficient to last for only approximately 6 seconds or 
less of maximal high intensity exercise (Gaitanos et al., 1993). During intermittent exercise, should 
the rest period not be long enough for full PCr resynthesis, each successive bout will begin with 
lower PCr and therefore less of a reliance on this energy store. When most PCr has been 
hydrolysed, a greater demand is placed on Oi-independent glycogenolysis and glycolysis 
(Urhausen and Kindermann, 1992). 
In summary, if Cr is only rephosphorylated in resting muscle, then there would be no role for the 
'Cr-PCr shuttle' or 'PCr circuit' during exercise and the contribution of PCr to ATP maintenance 
could be calculated directly from the decline in PCr from rest to exhaustion. If this were the case, 
then all other ATP would diffuse from glycolytic sites or from the mitochondria to the myofibrils. 
However, it seems likely that there should be a turnover of PCr which is made possible by the 
'shuttle' and therefore, the level of PCr seen during more prolonged exercise is a steady state 
concentration which is influenced by the rates in the following sequence: rate of PCr utilised for 
ADP rephosphorylation near the myofibrils, rate of Cr diffusion from the myofibrils back to the 
mitochondria, rate Cr can be rephosphorylated at the mitochondrial membrane and the rate of 
diffusion of PCr back to myofibrils. 
2.1.2 THE 0 2-INDEPENDENT GLYCOL YTIC SYSTEM 
While the reactions of the phosphagen system can be accelerated rapidly, the glycolytic pathway 
takes several seconds to be activated. Its activation is dependent largely on the demand of ATP 
being so high that large amounts of ADP accumulate and are subsequently deaminated to AMP, 
this occurs simultaneously with decreases in PCr and the resulting increases in Cr and Pi. The 
accumulation of ADP, AMP, IMP and Pi in particular cause the enzyme, glycogen phosphorylase 
b to convert to its more active form glycogen phosphorylase a, also increasing its activity and 
thereby stimulating glycogenolysis (as reviewed by Spriet, 1995). The products of ATP utilisation 
( excluding IMP) also cause the allosteric activation of PFK, thereby stimulating glycolysis by 
increasing the flux through the PFK reaction (as reviewed by Spriet, 1995). 
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This pathway produces ATP from the breakdown of muscle glycogen and plasma glucose without 
oxygen consumption and is therefore the pathway that is activated to a large extent when exercise 
is so intense that neither the phosphagen system nor the oxidative processes can keep up with the 
ATP demand. Alternatively, it is the pathway activated early in exercise before cardiac output and 
muscle blood flow increase. Concomitant with the production of ATP is the formation of lactate 
and the release of hydrogen ions. Thus, the level of lactate in the blood can be seen to be an 
indicator of the extent of 02-independent glycolytic activity. Hydrogen ion formation causes a 
drop in intracellular pH and this has a direct effect on the acto-myosin cross-bridges by decreasing 
force production (Cooke et al., 1988) and work output over time (de Haan et al., 1989). 
Hydrogen ions are allosteric inhibitors of phosphorylase and PFK, however, their effect seems to 
be largely negated by the strength of the allosteric activators of these enzymes (as reviewed by 
Spriet, 1995). It is therefore hypothesised that an increased availability of PCr may decrease 
hydrogen ion formation through less activation of the glycolytic processes and therefore help with 
the maintenance of force output in the working muscle. The phosphate liberated by PCr 
breakdown also increases the buffering capacity of the working muscle which should further help 
to reduce intracellular hydrogen ion accumulation (Harris et al., 1976). 
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The energy produced as a result of the activation of 0 2-independent glycolysis is sufficient to last 
for approximately 1 minute of intense exercise before Pi and hydrogen ion accumulation cause 
fatigue. (Hawley and Hopkins, 1995). For more sustained activity, therefore, Pi accumulation from 
nett PCr breakdown has to be limited and hydrogen ions from glycolytic ATP turnover have to be 
transported into the mitochondria together with pyruvate. In addition, ATP must be produced by 
mitochondrial oxidative phosphorylation which is fueled by both CHO and fat. This will occur at 
lower exercise intensities than those which rely on non-oxidative pathways. 
2.1.3 THE AEROBIC GLYCOL YTIC AND LIPOL YTIC SYSTEMS 
The duration and intensity of the activity and the substrate availability will determine the 
predominant fuel that is used during sub-maximal exercise (Hawley and Hopkins, 1995). The 02-
dependent glycolytic system will provide most of the energy for short-term endurance exercise (30 
minutes - 2 hours) while the 0 2-dependent lipolytic system is increasingly used for more prolonged 
activities (2 hours and longer) due to either further decreases in exercise intensity, decreasing 
CHO availability or metabolic and hormonal activation of lipolysis (Hawley and Hopkins, 1995). 
Thus, unless CHO is ingested, the lower the exercise intensity or the longer the duration, the 
greater the dependence on lipid relative to carbohydrate (Edwards et al., 1934). The aerobic 
systems are also termed oxidative or 0 2-requiring processes. 
Therefore, as stated previously, the major aim of these four systems is to provide ATP for 
contraction through rephosphorylation of ADP and through this maintain the ATP:ADP ratio at 
the myofibrils at optimal levels. However, another process may be activated in order to maintain 
an optimal ATP:ADP ratio for contraction. This process removes excess ADP that accumulates, 
as a result of an inability to rephosphorylate ADP fast enough, by degrading it. 
2.1.4 THE PURINE NUCLEOTIDE CYCLE 
Failure of the energy systems to rephosphorylate ADP to ATP displaces the myokinase 
equilibrium towards AMP formation: ADP+ ADP ~ATP+ AMP. The AMP can be deaminated 
to inosine monophosphate (IMP) by AMP deaminase with the release of ammonia (NH3). It 
should be noted that ADP, AMP, IMP are regulators of glycogen phosphorylase b and 
phosphorylase a and that ADP,AMP and the ammonium ion, NH/are regulators of PFK 
(Hargreaves, 1995; Spriet, 1995; Tull son and Terjung, 1991) and through these the PNC is 
involved in CHO metabolism. 
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In the activation of the purine nucleotide cycle (PNC), the rises in ADP, Pi and hydrogen ions 
resulting from high energy demand and the use of CHO cause the allosteric activation of AMP 
deaminase (Lowenstein, 1990). The NH3 produced from the AMP deaminase reaction 
subsequently appears in the blood and has been used as an indicator of the degree of adenine 
nucleotide degradation and AMP deaminase activity (Banister and Cameron, 1990; Broberg and 
Sahlin, 1989; Graham et al., 1990; Sewell and Harris, 1992). The extent ofNH3 release is 
dependent on the exercise intensity, duration and also on the exercise mode (Bouckaert and 
Pannier, 1995). Large quantities appear in the blood following highly intense or very long periods 
of exercise (Urhausen and Kindermann, 1992). Resting levels are reported to be from 20 to 25 
µmoll l in venous blood (Banister and Cameron, 1990). Values ofup to 250 µmoll l have been 
reported after highly intense cycling lasting up to 5 hours (Brouns et al., 1990). Katz et al., (1986) 
have reported resting levels of 95 µmoll l increasing up to approximately 220 µmoll l following a 
10 minute warm-up at 50 % V02max and a subsequent maximal cycle at 100% of V02max- However 
in exercise of long duration at least some of the plasma NH3 may be due to amino acid catabolism 
(Banister and Cameron, 1990). 
One of the consequences of an increase in plasma NH3 is that NH3 crosses the blood-brain barrier 
by diffusion (Banister and Cameron, 1990). In clinical conditions of elevated plasma NH3, 
symptoms of central and peripheral fatigue become evident (Banister et al., 1985; Wagenmakers, 
1992). Thus far however, scientific evidence for exercise-induced elevated plasma NH3 resulting in 
the development of central fatigue is inconclusive .. Research seems to implicate elevated plasma 
NH3 with the development of peripheral fatigue in as much as elevated muscle NH3 stimulates 
glycolytic activity and therefore depletes limited CHO stores (Wagenmakers, 1992). 
Muscle fibre type and recruitment also influence NH3 production. The fibres which have the 
highest AMP deaminase activity (Type IIB) also produce the most NH3. The greatest NH3 
production therefore occurs during exercise which activates Type IIB fibres, such as during high-
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intensity near-maximal or maximal activity in human subjects (Broberg and Sahlin, 1989; Dudley 
and Terjung, 1985a; Dudley and Terjung, 1985b; Meyer and Terjung, 1980; Tullson et al, 1990; 
Tullson and Terjung, 1990) and intense stimulation of fast twitch muscle in animal models (Meyer 
et al., 1980). 
The IMP produced from AMP deamination may be broken down subsequently to hypoxanthine 
(Hx), xanthine (X) and urate (Ur) or alternatively reaminated in a two-step process to AMP 
(Lowenstein, 1990) (see Figure 2). Reamination of IMP is an energy requiring process, which 
utilises GTP, but reduces the potential loss of adenine nucleotides from the cell and to some extent 
restores muscle ATP levels (Broberg and Sahlin, 1989; Tullson and Terjung, 1990). The 
reamination of IMP seems to operate mainly during recovery following intense short duration 
exercise (Meyer and Terjung, 1980) or alternatively, the deamination and reamination pathways 
may act in concert, but not simultaneously, as a cycle during more moderate exercise (Lowenstein, 
1990; Tullson and Terjung, 1991). This is because adenylosuccinate synthetase is activated with 
relatively low IMP accumulation, but is inhibited by high levels of IMP (Tullson and Terjung, 
1991). 
Hx, X and Ur can diffuse from muscle to blood and are therefore also used as blood-based 
markers of adenine nucleotide degradation (Bangsbo et al., 1992; Sewell and Harris, 1992; Stathis 
et al., 1994; Sutton et al., 1980). Despite its diffusion capacity, muscle Hx represents the final 
point at which adenine nucleotides can be recycled back to IMP via a pathway called the Purine 
Salvage Pathway and subsequently via the reaminating limb from IMP to AMP and then to ATP 
(Tullson and Terjung, 1991). The breakdown reactions to X and Ur are one-way reactions 
ultimately resulting in a nett loss of adenine nucleotides from the cell. These lost adenine 
nucleotides are only slowly and energetically expensively replaced through de novo synthesis 
(Tullson et al., 1988; Tullson and Terjung, 1990; Tullson and Terjung, 1991). This entire system 
of deaminating and reaminating cycles is termed adenine nucleotide metabolism (ANM) or the 
PNC. 
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2.2 CONTRIBUTIONS OF THESE SYSTEMS DURING ONE-HOUR EXERCISE 
Depending on the duration and intensity of the exercise bout, some or all of the energy systems 
may be in operation at one time. For example, a 3 hour endurance event at approximately 70% 
V02max the body will tend to rely largely but not exclusively on Oi-dependent oxidation of CHO. 
However, phosphagen and 0 2-independent glycolysis may contribute significantly to ATP 
resynthesis early on in exercise or intermittently with a change in pace and aerobic lipolysis may 
become increasingly active as the exercise tends to 3 hours if the subjects become CHO depleted. 
(Hawley and Hopkins, 1995) 
During shorter events lasting approximately one-hour, the exercise intensity is such that the energy 
demand is high for the entire hour (typically 89 % of maximum heart-rate for a 40 km time trial -
Palmer et al., 1995). Under these circumstances, it is likely that greater activation of the 
phosphagen system will occur at the onset of the exercise bout as well as intermittently during the 
course of the hour with changes in pace. However, Oi-independent and 02-dependent CHO 
degradation will be the two main energy sources. It is not known to what extent adenine 
nucleotide degradation will occur at this pace (Katz et al., 1986). Thus, one of the contributors to 
metabolism in one-hour exercise is the phosphagen system and its associated functions which 
facilitate the faster transport of 'high-energy' phosphagens from the mitochondria to the myofibrils 
than would be possible by simple diffusion of ATP alone ( see 2. 1. 1). Thus, were it not for the 
efficient operation and integrated action of the energy systems and adenine nucleotide control, it 
would be difficult for exercise to continue at a very high intensity for an hour (Astrand and 
Rodahl., 1970, Hawley and Hopkins, 1995). 
2.3 THE EFFECT OF CREATINE SUPPLEMENTATION ON PERFORMANCE AND 
METABOLISM 
2.3.1 GENERAL 
A 70 kg man has on average 120 g of total Cr (TCr, the sum of Cr and PCr) stored in his body 
(Crim et al., 1976). This pool of Cr is replenished at a rate of approximately 2 g per day to 
replace the Cr that is lost through the daily non-enzymatic breakdown of Cr to creatinine. Cr is 
12 
replaced either through biosynthesis or an uptake of dietary Cr (Walker, 1979). Cr is synthesised 
from the amino acids arginine, glycine and methionine (Crim et al., 1976; Walker, 1979) and this 
occurs in the liver, pancreas and kidneys. From these organs it is transported in the blood for 
uptake by muscle. Despite synthesis taking place in other organs, Cr is found mainly in skeletal 
muscles and to a lesser extent in cardiac and smooth muscle. Skeletal muscle Cr concentrations 
depend on muscle fibre type (Edstrom et al., 1992, Tesch et al., 1989). The highest concentrations 
of Cr are found in fast-twitch (white) muscle. Both Cr and its precursors are found predominantly 
in meat, chicken and fish and Harris et al., (1992) have found lower than normal levels of Cr in the 
muscles of two vegetarians. However they seemed to be unaffected in daily life activities by their 
lower intramuscular Cr store (Harris et al., 1992). 
An area of exercise physiology that has, until recently, received little interest is the effect of 
nutritional supplementation, using Cr, upon short-term high intensity exercise capacity. This is 
surprising given that many individual events ( such as running, cycling and rowing) and almost all 
team sports, rely heavily on the 'high energy phosphate' pathways to provide energy for muscular 
contraction. Indeed, even athletes participating in endurance events of long duration intermittently 
increase their exercise intensity, particularly during the final 30 seconds of a race, and although 
PCr is not a primary fuel source, it may be of significant secondary importance. 
Research on Cr supplementation in humans was begun as early as 1926, with studies focusing 
primarily on the way Cr is metabolised by the body (Chanutin, 1926; Crim et al., 1975) and on the 
size of the body Cr pool (Crim et al., 1976). The early studies did not require ingestion oflarge 
quantities of Cr and despite the fact that most of the body's Cr is stored in muscle, the 
investigators did not perform muscle biopsies. Therefore no conclusions could be made about the 
effect of supplementation on the intramuscular store of Cr. 
But, a recent landmark study, which included muscle biopsies, showed that oral Cr 
supplementation of 20 grams of Cr per day for three days or more could significantly increase 
muscle Cr content (Harris et al., 1992),. This increased the size of the PCr pool available to 
rapidly provide fuel for ATP resynthesis (Harris et al., 1992). 
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2.3.2 CREATINE SUPPLEMENTATION AND EXERCISE PERFORMANCE 
The study by Harris et al., (1992) prompted other studies that sought to examine the effect of the 
above supplementation regimen on exercise performance. Maximal, short duration exercise 
regimens were chosen since it was assumed that the major effect of Cr supplementation (and the 
resulting increased muscle PCr stores) would occur under these exercise conditions. 
In summary, these studies have shown that Cr supplementation does not improve maximal exercise 
performance but does improve subjects' resistance to fatigue during short, intermittent, maximal 
exercise tests so that performance is enhanced during the later stages of the tests (Balsom et al., 
1993a; Birch et al., 1994; Earnest et al., 1994 (Abstract); Greenhaff et al., 1993a; Lemon et al., 
1995 (Abstract); Soderlund et al., 1994 (Abstract); Viru and Nurmeviki, 1993). The exercise 
protocols varied and included high intensity cycle ergometry involving 10 repetitions of 6 s 
maximal sprints with 30 s rest (Balsom et al., 1993a), 3 sets of 30 s maximal isokinetic sprint 
cycle bouts with 4 minutes rest between bouts (Birch et al., 1994), 3 sets of 30 s maximal cycle 
sprints with 5 minutes rest between bouts (Earnest et al., 1995 (Abstract)), 5 sets of 30 repetitions 
of maximal isokinetic knee extensions on a cybex with 1 minute rest between sets ( Greenhaff et 
al., 1993 a), 20-3 0 s of maximal isometric ankle extensions with 16 s rest between sets (Lemon et 
al., 199 5 (Abstract)), 5 sets of 6 s cycle sprints with 3 0 s rest between sets and 1 set of 10 s cycle 
sprint with 40 s rest prior to the bout (Soderlund et al., 1994 (Abstract)) and running time trials of 
4 repetitions of 300 m and 1 km with 3-4 minutes rest respectively between repetitions (Viru and 
Nurmekivi, 1993). It should be noted that of these studies only two (Greenhaff et al., 1993a and 
Lemon et al., 1995 (Abstract)) performed muscle biopsies and therefore determined the muscle Cr 
concentration before and after supplementation. 
However, more recent research does not seem to concur. Preliminary reports of studies by Almada 
et al., (1995) (Abstract); Burke et al., (1995) (Abstract); Cooke et al., (1995); Grindstaff et al., 
(1995) (Abstract); Odland et al., (1994) (Abstract); Redondo et al., (1995) (Abstract) and Stroud 
et al., ( 1994) have indicated that Cr supplementation does not enhance performance under a 
variety of exercise conditions. These conditions include maximal bench-press and squat (Almada et 
al., 1995 (Abstract); Grindstaff et al., 1995 (Abstract)), swim sprints up to 100 m (Burke et al., 
1995 (Abstract)), 2 sets of 15 s maximal cycling with 20 minutes rest between sets ( Cooke et al., 
1995), one maximal 30 s cycle sprint (Odland et al., 1995 (Abstract)), multiple 60 m sprints 
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(Redondo et al., 1995 (Abstract)) and a submaximal incremental run at different workloads 
adjusted every 6 minutes (Stroud et al., 1994). It is unknown whether or not the subjects actually 
Cr loaded since muscle biopsies were not performed and without this data it is difficult to 
determine the reasons for the unchanged performances. These protocols were not markedly 
diff eent from those in which performance improvements were noted. 
2.3.3 CREATINE SUPPLEMENTATION AND CARBOHYDRATE METABOLISM 
Cr and its effect on carbohydrate metabolism has indirectly been studied through the measurement 
of plasma pH and plasma lactate during exercise, before and after Cr loading. Conflicting evidence 
has been reported. Several studies (Balsom et al., 1993b; Birch et al., 1994; Greenhaff et al., 
1993a; Stroud et al., 1994) have reported no change in blood lactate levels in either the placebo or 
Cr group following supplementation, suggesting that the administration of Cr does not affect the 
utilisation of the non-oxidative glycolytic and glycogenolytic process for providing energy for 
contraction. This was found for exercise modalities ranging from repeated bouts of maximal 
exercise lasting a total of approximately 1 minute (Balsom et al., 1993a) to submaximal 
incremental exercise lasting a total of approximately 42 minutes (Stroud et al., 1994). Studies by 
Balsom et al., (1993a) and Soderlund et al., (1994)(Abstract) showed that when performing high-
intensity intermittent exercise lasting 6 s, those individuals who were supplemented with Cr had 
lower plasma lactate levels. These groups of researchers postulated that under Cr loaded 
conditions, the processes of non-oxidative glycolysis and glycogenolysis (and thus the production 
oflactate and hydrogen ions) will be utilised to a lesser extent during very short exercise bouts 
simply because the larger store of PCr is providing energy for a greater proportion of the exercise 
bout. 
While the initial studies have provided some insight into the effects of the supplementation 
regimen on exercise performance, the performances that have been measured are generally of a 
short duration and supramaximal intensity. The effects of Cr supplementation on performance and 
metabolism described in these studies are applicable to only that type of exercise and the results 
cannot be extrapolated to other types of exercise. However, we hypothesise that higher PCr levels 
may result in less allosteric activation of the enzymes involved in non-oxidative glycolysis and 
glycogenolysis during exercise of longer duration. The result of this will be a lesser demand on 
glycolytic and glycogenolytic processes early on in the exercise bout, and thus lower plasma 
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lactate levels and possibly less of a decrease in intramuscular pH. In addition, oxidative 
phosphorylation plays a major role when in exercise, such as endurance exercise, the processes are 
linked with the ATP being produced by the mitochondria ( as a result of oxidative breakdown of 
glucose, glycogen, fat or protein). This ATP is then transported to the contractile proteins of the 
myofibril via the 'Cr-PCr shuttle' and this may be more efficient with higher levels of TCr resulting 
in greater oxidative energy supply. 
2.3.4 CREATINE SUPPLEMENTATION AND THE PURINE NUCLEOTIDE CYCLE 
The initial studies on Cr supplementation while examing the effect of Cr on performance also 
measured plasma NH3 (Birch et al., 1994; Greenhaff et al., 1993a) and Hx (Balsom et al., 1993a; 
Balsom et al., 1993b) levels as markers of adenine nucleotide degradation. However, plasma NH3 
is merely a marker of the extent of activity of AMP deaminase which deaminates AMP to IMP and 
thus indicates the extent of adenine nucleotide degradation to IMP (see 2.1.4). The use of other 
markers such as Hx and Ur aid in determining the extent to which the cycle as a whole has been 
functioning, with plasma Ur being an end marker of complete loss of adenine nucleotide from the 
cell. For this reason Ur could be viewed as an indicator of the degree to which de novo synthesis 
of adenine nucleotides needs to occur to subsequently replenish these lost adenine nucleotides. 
Greenhaff et al., (1993a) found that oral Cr supplementation lowered plasma NH3 levels post-
supplementation during 5 sets of 30 repetitions of maximal isokinetic knee extensions with I 
minute rest between sets. Birch et al., (1994) found lowered plasma NH3 following 3 sets of 30 s 
cycle sprints with 4 minutes rest between sets. Similarly the results ofBalsom et al., (1993a) show 
that plasma Hx accumulation is decreased following Cr supplementation. As stated in the previous 
section, it is not possible to extrapolate results from maximal, short duration exercising situations 
to exercising conditions lasting one-hour. Balsom et al., (1993b) found no change in plasma Hx 
levels following a 6 km terrain run. Thus, a plasma NH3 lowering effect may not occur during 
endurance exercise. In summary, the majority of the results of these initial studies have indicated 
that Cr supplementation can decrease the activity of the PNC during the later bouts of short-
duration, maximal exercise or maximal intermittent exercise. This suggests more efficient 
maintenance of the ATP:ADP ratio, thence less activation of the PNC and less adenine nucleotide 
degradation when Cr supplemented. This effect may be due to either greater PCr availability or 
faster PCr resynthesis or both. 
16 
2.3.5 CREATINE SUPPLEMENTATION AND PHOSPHOCREATINE RESYNTHESIS 
The effect of oral Cr supplementation on PCr resynthesis during recovery from intense, exhaustive 
exercise has been investigated and two studies indicate that PCr resynthesis is improved when Cr 
loaded ( Greenhaff et al., 1994a; Greenhaff et al., 1993 b). These two studies used electrical 
stimulation to induce isometric contraction of the quadriceps. The exercise involved 20 
contractions lasting 1.6 s with 1.6 s rest. The tests were performed with and without occlusion of 
blood flow and pre and post Cr supplementation. These studies found an accelerated rate of PCr 
resynthesis after Cr supplementation especially in those individuals with the lowest levels of TCr 
prior to supplementation. This may explain the mechanism behind the performance improvements 
found in the latter bouts of exercise in several of the Cr supplementation studies described 
previously. Accelerated PCr resynthesis can result in an enhanced potential to perform maximally 
during subsequent exercise because there is a larger amount of high-energy phosphate available for 
transfer to ADP for resynthesis of ATP and less reliance on non-oxidative glycolysis with 
consequently less hydrogen ion production and better force maintenance. 
2.4 CREATINE SUPPLEMENTATION AND ONE HOUR EXERCISE 
As mentioned previously, Cr has another biochemical function which is to shuttle 'high-energy' 
phosphate formed during oxidative phosphorylation from the mitochondria to the working muscle 
proteins. During sub-maximal intensity exercise it is not expected that PCr breakdown itself would 
contribute substantially to the energy requirements, but that the glycogenolytic-glycolytic systems 
and oxidative phosphorylation would be the major contributors. Indeed, oxidative phosphorylation 
could contribute between 40 and 70% of the energy requirements depending on the intensity and 
the duration of the exercise (Astrand and Rodahl, 1970; Hawley and Hopkins, 1995). Thus, a 
possible benefit of increased muscle Cr stores could be an improved capacity to transport 'high-
energy' phosphate in the form of PCr from the mitochondria to the contractile proteins where the 
'high-energy' phosphate is utilised to rephosphorylate ADP to ATP thereby increasing the 
contribution of oxidative processes to energy requirements and decreasing the utilisation of non-
oxidative glycogenolysis and glycolysis and delaying the accumulation of fatigue-inducing 
metabolites. To date no performance tests longer than 24 minutes of running have been 
performed (Balsom et al., 1993b ), although CHO metabolism has been studied for 42 minutes at 
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submaximal exercise intensities (Stroud et al., 1994) with subjects who have been Cr 
supplemented. Thus the potential of Cr as an ergogenic aid for endurance athletes warrants further 
investigation. 
During metabolically stressful situations a sub-optimal ATP:ADP ratio results in ADP degradation 
to AMP and inosine monophosphate (IMP) (Lowenstein, 1990; Sahlin and Broberg, 1990; Sewell 
and Harris, 1992; Tullson and Terjung, 1991) and later to Hx, X and Ur (Hellsten-Westing et al., 
1994; Sutton et al., 1980). This results in a loss of adenine nucleotide from the muscle pool, but 
does maintain the ATP:ADP ratio for a period thereby allowing muscular activity to continue. No 
study has investigated whether an increased availability of PCr, which facilitates the resynthesis of 
ATP from ADP and PCr, will decrease ADP breakdown and adenine nucleotide loss from the 
muscle pool during endurance exercise and whether this will translate into improved performance. 
However indirect evidence from plasma NH3 and Hx levels suggest that this may be the case as 
these plasma markers of adenine nucleotide loss are decreased following Cr supplementation 
(Balsom et al., 1993a; Birch et al., 1994; Greenhaff et al., 1993a). 
Despite the integrated nature of metabolic control during exercise and the role of Cr in several 
processes, no research has examined the effects of creatine supplementation on performance or 
metabolism during one-hour endurance exercise. We therefore proposed to test the effects of 
creatine supplementation on performance and metabolism during a distance trial consisting of one-
hour near maximal endurance cycling effort. Metabolic investigations included plasma lactate, 
NH3, Hx and Ur; and muscle ATP, ADP, AMP, PCr, Cr and glycogen. The mechanism of action 
of creatine under these conditions was proposed to be an effect on the efficiency of the 'Cr-PCr 
shuttle' resulting in alterations in adenine nucleotide metabolism. We hypothesised that Cr loading 
would result in maintainance of PCr at higher levels during sub-maximal exercise and improved 
rephosphorylation of ATP so that the blood based indicators of adenine nucleotide catabolism 
would be lowered. We also hypothesised that performance would improve which would indicate 
that the ATP:ADP ratio is being more closely regulated because of the greater availability of Cr, 
consequently the onset of fatigue as a result of an accumulation of ADP and other fatigue-inducing 
metabolites would be delayed. 
CHAPTER 3: METHODS AND MATERIALS 
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CHAPTER 3: METHODS AND MATERIALS 
3 .1 SUBJECTS 
Twenty male endurance cyclists volunteered for the study. They were recruited on the basis of 
their ability to cycle approximately 40 kilometres in one hour. In addition they were required to 
have covered a distance of 105 kilometres in a cycle race in under 3 hours, and at the time of the 
study they should be participating in regular endurance training. The subjects received an 
information sheet outlining the procedures for the test period (Appendix 1) and were then required 
to sign an informed consent form (Appendix 2). In addition, they understood that they were able 
to withdraw from the study at any time if they so desired. The study was passed with ethical 
approval by the University of Cape Town Ethical Research Committee for research in human 
subjects. 
3.2 EXPERIMENTAL PROCEDURE 
This study was a placebo controlled, double-blind laboratory experiment to determine the effect of 
Cr ingestion on endurance exercise performance and metabolism. At no stage were either the 
investigator or the subjects aware of the nature of the tablets being ingested and both were 
unblinded only after analysis of all samples. The 2 week test period consisted of an initial week of 
familiarisation of the subjects with the exercise tests. Initially, each subject was required to 
perform a Peak Sustained Power Output (PPO) test (see 3.3 for detail) in order to assess their 
level of fitness and therefore their suitability for the trial. Two days later the subject was required 
to bring his own bicycle into the laboratory for attachment to a wind-braked cycle ergometer 
(Kingcycle, Version 4.1, 1991, EDS Portaprompt Limited, High Wycombe, Bucks). The subject 
then completed a one-hour distance cycle. This was performed under identical conditions to those 
under which the subjects were to perform during the trial period. This required that the subject 
only receive water to consume during the one-hour cycle and was unaware of distance covered, 
speed and power output. They were aware only of the length of time they had been cycling. 
Following this each subject was required to record his training for the familiarisation week prior to 
Test 1 (T 1) and his diet for the three days prior to T 1. Each subject was then asked to maintain the 
same training and diet for the second week of the trial, prior to Test 2 (T2). 
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Prior to Tl each subject was required to undergo a muscle biopsy (see 3.5 for detail) and the 
insertion of an in-dwelling cannula so that venous blood could be sampled at various time points 
(see 3.7 for detail). The subject then performed the one hour cycle during which he was to cover 
as much distance as possible. Total distance covered and heart-rate (Polar Vantage XL, Polar 
Electro, Finland) were recorded. Following the cycle each subject was given a bag containing 
either the placebo (supplied by LMN, England) or the Cr supplement (Ergomax, LMN, England). 
These tablets were exactly the same size, texture and weight. They were then instructed to 
consume 5 tablets four times per day for the following week and to record the time of day the 
tablets were taken and how they felt physically and psychologically after taking them. In addition 
they were instructed to dissolve the tablets in hot water, to minimize the conversion of Cr to 
creatinine, and to take each batch of five tablets before a main meal and the fourth batch either 
one hour before training or before going to sleep on a rest day. 
Upon completion of the Cr loading week the subjects again reported to the laboratory and 
underwent a second muscle biopsy and insertion of a cannula. They again completed a one hour 
distance cycle (T2) to compare the effect of the loading week on performance and metabolism 
during the one-hour test. 
3.3 THE PEAK POWER OUTPUT (PPO) TEST 
This test is a routine laboratory test and was performed according to the protocol of Hawley and 
Noakes (1992). The test has been validated and is a reliable and consistent measure of the maximal 
sustained power output that can be performed by the athlete. A close correlation has been 
reported between peak workload achieved and V02max using this protocol (r=0.97, p<0.0001). 
The exercise test is performed on a calibrated cycle ergometer (Lode, Groningen, Nederland). The 
starting workload is that workload which is determined as 3.33 Watts (W) per kilogram (kg) of 
the subject's weight. This workload is then increased every 2.5 minutes by 50 W for the initial 2 
workloads and thereafter by 25 W until voluntary exhaustion of the subject or where the subject 
fails to maintain a cadence of greater than 70 revolutions per minute (rpm). The time of cessation 
of the test is recorded and the peak sustained power achieved by the subject is calculated 
according to the formula: 
Peak Power Output (PPO) = ( time at final workload * 25 (W) ) + previous workload (W) 
150 sec 
The resulting PPO may also be used to predict V02max using the equation: 
V02max = (0.01141 (PPO) + 0.435) 
In addition, the subjects' power to weight ratio can be calculated using the formula: 
P:W=PPO(W) 
mass (Kg) 
This allows for comparison between individuals of different mass and thus takes into account the 
relative power that each individual produces rather than simply the absolute power produced by 
the cyclist which takes no account of body mass or size. 
3.4 THE KINGCYCLE 
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The subjects cycled on their own bicycles during the familiarisation, Tl and T2 one hour cycles. 
Their bicycles were attached to the 'Kingcycle' ergometer (Version 4.1, 1991, EDS Portaprompt 
Limited, High Wycombe, Bucks.). This system involves the attachment of the front bicycle forks 
to a frame and the resting of the bottom bracket on an adjustable prop. Adjusting the prop alters 
the amount of rolling resistance applied to the rear wheel. Power is produced through the rolling 
of the rear tyre against a calibrated air brake and flywheel. The mass of the flywheel and the 
resistance of the air brake are engineered to simulate the inertial load experienced by a 65 kg 
cyclist and his bicycle. Cadence and power output are measured by a system of photo optic cells. 
The whole system is linked to an IBM compatible PC and the data is recorded and displayed 
continuously. This system has proven reliability (coefficient of variation= 1.0 ± 0.5 % for three 40 
km time trials , Palmer et al., 1995), and results of maximal aerobic power tests performed on the 
Kingcycle indicate a test retest correlation ofr=0.98 (Keen et al., 1991). 
Prior to each test the Kingcycle was calibrated for each cyclist on his bicycle utilising a run down 
calibration. Calibration is achieved by altering the rolling resistance by manually altering the 
adjustable prop. This serves to ensure the results of the tests performed on the Kingcycle are both 
comparable and repeatable. The advantage of this system is that it allows the cyclists to be tested 
under conditions that more closely approximate road cycling and allows the cyclists to use their 
own bicycles. 
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3.5 MUSCLE SAMPLING 
Muscle biopsy samples were taken on two occasions from the vastus lateralis muscle using the 
technique designed by Bergstrom et al. (1962) as modified by Evans et al. (1982). Some of the 
subjects (n = 10) did however, consent to having a third post-exercise biopsy. The muscle biopsies 
were taken under sterile conditions and performed by a qualified medical doctor with experience in 
this procedure. Prior to incision the skin was cleaned and prepared for administration oflocal 
anaesthetic. Following this approximately 3 ml oflignocaine (2% m/v Lignocaine, Intramed, Port 
Elizabeth, RS.A.) was injected below the skin to the level of the muscle fascia. Once sufficient 
time had passed to allow the anaesthetic to act, a scalpel incision was made through the skin and 
fascia to the level of the muscle. The muscle biopsy needle was then inserted and a sample taken 
within 2 seconds of insertion. The muscle sample was then placed in a vial and frozen in liquid 
nitrogen and subsequently stored at -80°C. The time from taking of the biopsy to freezing was 
estimated to be 6 seconds. Pressure was then applied to the wound until the bleeding stopped, the 
biopsy wound was then disinfected with Spray Benzco (Beige Pharmaceuticals, Edenvale, RS.A.), 
closed using Steristrip skin closures (3M, St. Paul, US.A), covered with Tegaderm (3M, Canada 
Inc., Ontario) and bandaged. 
The frozen muscle sample was later freeze-dried and used for analysis of Cr, PCr, ATP, ADP, 
AMP and glycogen contents. Thus, the muscle samples were saved and pre and post samples were 
analysed together at a later date. The method used for determination of the high-energy 
phosphates and nucleotides was a modification of the High Performance Liquid Chromatography 
(HPLC) method used by Sellevold et al., (1986). Muscle glycogen content was analysed by a 
modified method of Keppler and Decker in Bergmeyer ( ed), 1981. 
3 .6 HPLC METHOD FOR DETERMINATION OF MUSCLE NUCLEOTIDE CONTENTS 
This method is based on that described by Sellevold et al., (1986). Certain modifications were 
made to provide better resolution of peaks in our apparatus. The equipment used for analysis 
included a Gilson Instruments HPLC (Gilson Inc., Middleton, US.A) using a Gilson 305 pump 
(Gilson Inc., Middleton, U.S.A), a Rheodyne 7125 injection valve (Rheodyne, California, US.A) 
and Gilson UV/ VIS detector (l 19UV) (Gilson Inc., Middleton, US.A). The column used was an 
Alphasil SODS 25 cm x 4.6 mm. The flow rate was set at 0.6 ml/ min from Oto 8 minutes, 
thereafter increased to 1.2 ml/ min until 19 minutes whereupon it was again reduced to 0.6 ml/ 
min. The total run time was 20 minutes. The injection loop consisted of 20 µI of sample. 
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The method used consisted of a mobile phase of phosphate buffer made up using 90 mM 
potassium dihydrogen phosphate (BDH, Hypersolv, England), 3.5 % HPLC-grade acetonitrile 
(BDH, Hypersolv, England) and 2,3 mM tetrabutylammonium hydrogensulphate (TBAHS) (TCI-
Ace, Tokyo Kasei Kogyo Co. Ltd., Tokyo). The buffer was then titrated to pH 6.5 using 40 % 
KOH and subsequently made up to volume using distilled, 18 Mohm water. Following this the 
buffer was filtered and degassed. 
Standards were made up using mobile phase buffer and were divided into aliquots and frozen at -
20°C. Fresh standards were defrosted every morning and mixed together to form a combination of 
all the compounds expected in a muscle sample run. Thus, a high and a low standard mix were 
made up for injection onto the column. Standard runs were repeated at regular intervals during an 
analysis day. 
On any analysis day, a freeze-dried muscle sample was dissected free of connective tissue ( and in 
some samples blood) and approximately 5 mg dry wt weighed out. This sample was then 
homogenised in a glass homogeniser using 100 µI of ice-cold 0.6 M perchloric acid (PCA) (BDH, 
Hypersolv, England) with a further 900 µI being added susequently to make the volume up to 1 
ml. Homogenisation was continued until the muscle sample was well homogenised. The sample 
was then placed in a 1. 5 ml conical reaction vial and centrifuged in a micro-centrifuge (Eppendorf, 
Geratebau, Germany) for 4 minutes at 11500 rpm (8000g). Two 200 µI aliquots of supernatant 
were removed and placed in two reaction vials. In one vial 4 µI of universal indicator was added 
and titrated, with approximately 21 µI of 2.5 M K2C03 (Univ AR, Saarchem Pty Ltd, 
Krugersdorp) being added to neutralise the sample. Following this the same procedure was 
performed on the second vial without the addition of universal indicator. This vial was then placed 
on ice for 10 minutes to precipitate the potassium perchlorate, and then centrifuged for 4 minutes 
at 11500 rpm. After centrifugation 100 µl of supernatant was removed and made up to 1 ml in 
another reaction vial using 900 µI mobile phase buffer. After mixing, approximately 20 µI was 
removed from the vial and injected onto the column via the injection valve. 
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This modified method was found to produce good peak resolution of all compounds investigated 
(see Appendix 3). These compounds were Cr, PCr, ATP, ADP, AMP. These peaks were 
quantified relative to the average areas and heights of the standards which were recorded at the 
start and end of each day. In particular, Cr was analysed according to height at 210 nm while ATP 
was analysed according to area at 260 nm. 
3.7 BLOOD SAMPLING 
Blood samples were taken at regular intervals during Tl and T2. They were drawn through an 18 
gauge cannula and stopcock inserted into a forearm vein. The cannula was kept patent throughout 
the trial by regular flushings with sterile saline (0.9 % sodium chloride, Sabax, Johannesburg, 
RS.A.) containing 1 ml of heparin (Novo Nordisk, Johannesburg, RS.A.) per 100 ml saline. A 
blood sample was taken at rest and then at 10, 20, 40 and 60 minutes of the one-hour cycle and at 
2, 6 and 10 minutes of recovery. Prior to taking each sample, 1. 5 ml of blood was drawn and 
discarded. Following this approximately 3.5 ml of blood was drawn and placed on ice in 5 ml 
evacuated tubes (Vac-u-test, Radem Medical, Sandton, RS.A.) containing 15 % K3EDTA. This 
blood was then centrifuged (Sigma, GmbH, Germany) at 3000 rpm for 6 minutes at 3°C. 
Immediately after separation, 2 aliquots of 120 µl of plasma were removed from each sample and 
placed in a microcuvette (Halb-Mikro, Labortechnik, Greiner, Germany) and covered with 
parafilm for determination of plasma NH3 (within 40 minutes of sampling) using a commercially 
available kit (NH3, Boehringer Mannheim, Germany). The remaining plasma was removed and 
placed in plastic 1. 5 ml storage vials and stored at -25°C for later determination oflactate, Hx and 
Ur. The samples were therefore saved and pre and post samples were analysed together at a later 
date. Lactate was analysed using a commercially available kit (Lactate PAP, Biomerieux, France), 
while Hx and Ur were analysed by HPLC. 
3.8 HPLC METHOD FOR DETERMINATION OF HYPOXANTHINE AND URATE 
Plasma Hx and Ur were analysed using a Gilson Instruments HPLC (Gilson Inc., Middleton, 
US.A) using a Gilson 305 pump (Gilson Inc., Middleton, US.A), a Rheodyne 7125 injection 
valve (Rheodyne, California, US.A) and Gilson UV/ VIS detector (119UV) (Gilson Inc., 
Middleton, US.A). The column used was an Alphasil SODS 25cm x 4.6mm. This analysis method 
utilised a 50 mM potassium dihydrogen phosphate buffer (BDH, Hypersolv, England) made up 
using distilled 18 Mohm water. Following this the buffer was filtered and degassed. The flow rate 
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was set at lml/ min and the total run time was 10 minutes. Integration of peaks was only begun 
after 5 minutes of the run. Stock standards were made up and frozen. These were defrosted at the 
start of every day and made up to volume with mobile phase buffer. Extraction of the plasma 
samples was similar to that for muscle samples. This method involved adding I 00 µl of plasma to 
100 µl of ice-cold 0.6 M perchloric acid (PCA) (BDH, Hypersolv, England). The sample was 
centrifuged in a micro-centrifuge (Eppendorf, Geratebau, Germany) for 4 minutes at 11500 rpm 
(8000g). Following this 150 µl of supernatant was removed and neutralised with 9 µl of2.5 M 
K2C03 (Univ AR, Saarchem Pty Ltd, Krugersdorp, RS.A). This sample was then placed on ice for 
IO minutes and again centrifuged for 4 minutes at 11500 rpm. After centrifugation I 00 µl of 
supernatant was drawn off and made up to 500 µl with 400 µl mobile phase buffer. This sample 
was then injected onto the column. The injection volume was 20µ1 of sample. 
Both Hx and Ur were detected at 249 nm and analysis was performed according to area. This 
method provided good resolution of peaks in both standard and sample runs (see Appendix 4). 
3.9 TRAINING AND DIETARY RECORDS 
The subjects were all required to keep accurate log-books of their training sessions including 
distance, type of course, time taken and intensity ( on a scale of I to I 0) of the session during their 
2 weeks of testing. Their training in the initial familiarisation week was to be kept constant in the 
following week and this was recorded in a log-book In addition, the subjects were instructed to 
keep dietary records for the 3 days prior to T 1. The food that was consumed on those 3 days was 
then to be ( as closely as possible) consumed on the 3 days prior to T2 so that carbohydrate-
loading and differing dietary practices between Tl and T2 could largely be eliminated. The 
rationale for requesting these records was to closely control for an effect of diet thereby limiting 
the effect on performance and metabolism to that of the creatine supplement or placebo. 
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3.10 STATISTICAL ANALYSIS 
All statistical analysis was performed on Statistica (Statsoft Inc., Tulsa, Oaklahoma). For all 
statistical analysis of data on muscle compounds a two-way ANOV A with a repeated measure was 
used, while for all blood metabolites and heart-rate, a three-way ANOV A with repeated measures 
was used. Missing variables were deleted pairwise. Statistical significance was accepted when p< 
0.05. Where significant differences were found a Tukey HSD post-hoc test for unequal numbers 
was performed to determine where significant differences lay. 
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CHAPTER 4: THE EFFECT OF ORAL CREATINE SUPPLEMENTATION ON 
ONE-HOUR CYCLING PERFORMANCE AND METABOLISM 
4.1 RESULTS 
All results are expressed as means and standard errors of the mean(± SEM) for each group at 
each time point. Statistical analyses which are graphically displayed as significant are only the 
between group differences. Differences in plasma metabolite concentrations from rest were 
statistically significant at all time points during exercise and recovery. 
4.1.1 SUBJECT CHARACTERISTICS 
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There were no differences between the two groups for either age, height, mass or PPO, although 
both groups significantly increased their mass from Tl to T2 (p<0.01) (see Table I). 
4.l.2MUSCLEDATA 
Both groups significantly increased their muscle Cr from Tl to T2 (p<0.05) (see Figure 3a). The 
initial level of muscle Cr for the placebo and Cr group was 49. 8 ± 2. 0 mmol/ kg dry wt and 51. 1 ± 
5.0 mmol/ kg dry wt respectively. This increased to 54.6 ± 3.7 mmol/ kg dry wt in the placebo 
group and 67.6 ± 4.4 mmol/ kg dry wt in the Cr group following supplementation. Figure 3b 
indicates that muscle PCr did not significantly change in either group from Tl to T2. Total muscle 
Cr (TCr, the sum of Cr and PCr) showed a significant effect of Cr loading (p<0.001) (see Figure 
4). The Cr group increased their muscle TCr from 123.5 ± 3.8 mmol/ kg dry wt to 159.8 ± 7.9 
mmol/ kg dry wt. This represents a mean increase of29%. The placebo group was relatively 
unchanged from 126.7 ± 4.7 mmol/ kg dry wt to 127.5 ± 3.6 mmol/ kg dry wt. Figure Sa indicates 
the relationship between initial TCr and the degree to which Cr loading occurs. The relationship 
was not significant (r=0.46; p=0.19). 
No significant differences were found for ATP, ADP and total nucleotide (the sum of ATP and 
ADP since AMP concentrations were negligible) contents in any of these variables indicating that 
the two groups were similar and that Cr loading did not affect the intramuscular nucleotide levels 
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(see Table II). In addition, in those subjects with large enough biopsy samples for both Tl and T2, 
further analysis for muscle glycogen was performed. No significant differences were noted in 
terms of glycogen loading or utilisation in either the placebo (n=4) or the Cr group (n=6) (see 
Table 111). 
4.1.3 PERFORMANCE AND HEART-RATE DURING THE ONE-HOUR CYCLE 
The distance covered in the one-hour trial at TI was not different between the Cr and placebo 
groups. The Cr group marginally improved the distance covered in the one-hour cycling trial (39.1 
± 0.9 km to 39.8 ± 0.8 km) while the placebo group was unchanged (39.3 ± 0.8 km to 39.2 ± 1.1 
km). Figure Sb shows the correlation between the change in TCr and the change in distance 
covered in the creatine group. This relationship approaches significance (r=0.6, p=0.06), indicating 
that there is some relationship between the change in TCr levels and the degree to which 
perfomance improves. No significant differences were evident in the heart-rate data in or between 
either group for Tl or T2. 
4.1.4 TRAINING AND DIETARY RECORDS 
No significant differences were evident in the subjects training regimen before or during the Cr 
supplementation regimen. Similarly, the subjects reported the same or very similar dietary 
practices over the two week trial period and especially in the 24 hours prior to each trial. 
4.1.5 BLOOD DATA 
Figure 6a, b and c and Figure 7 display the concentrations of plasma NH3, Hx, Ur and lactate 
during the one-hour trials and 10 minutes ofrecovery. For absolute values of mean± SEM for 
each group at each time point see Appendix 5. It should be noted that although the Tl values for 
plasma NH3, Hx and Ur in the Cr group were higher, these were not significantly different. Plasma 
NH3 (see Figure 6a) was significantly different between groups, trials and over time (p<0.05). This 
indicates that the Cr and placebo groups responded differently from TI to T2 at several time 
points. Post-hoc analysis indicated where the differences were. 
Figure 6b displays the results of plasma Hx analysis. A significant difference (p<0.01) between the 
groups, trials and over time was noted indicating that the groups behaved differently from Tl to 
T2 at several time points. The exact location of these differences as determined through post-hoc 
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analysis are indicated on the respective graphs. The results of Ur analysis indicate a significant 
difference between Tl and T2 (p<0.01) when all the results are analysed together, indicating that 
both groups decreased. However, there were no differences between groups or between trials in 
each group separately (see Figure 6c). It is for this reason that the significant difference is not 
indicated on Figure 6c. Plasma lactate results are displayed in Figure 7. Statistical analysis revealed 
no significant differences in or between either group in Tl and T2. 
4.2 DISCUSSION 
The main finding of this study was that increases in intramuscular Cr stores were associated with 
decreased plasma NH3 and Hx concentrations during maximal one-hour exercise in comparison to 
the unloaded state and to controls who ingested placebo. This has only previously been found in 
studies examining the effect of Cr supplementation on metabolism during short-term maximal 
exercise (Balsom et al., 1993a; Birch et al., 1994; Greenhaff et al., 1993a). The alteration in 
metabolism in this study was not associated with an improvement in one-hour cycling performance 
and was not a result of alterations in dietary practices or training by the subjects participating in 
the study. 
The exercise performed in this study was of a high intensity but continued for one hour. During 
this type of exercise, energy is provided by several systems including the oxidative and non-
oxidative pathways, pathways of adenine nucleotide metabolism and 'immediate-energy' pathways 
involving the transfer of 'high-energy' phosphate. This is in contrast to the majority of previous 
studies that have to a large extent examined the effect of a similar Cr loading regimen, first 
described by Harris et al., (1992), on high intensity activity of short duration (Balsom et al., 
1993a; Birch et al., 1994; Cooke et al., 1995; Earnest et al., 1994 (Abstract); Greenhaff et al., 
1993a; Lemon et al., 1995 (Abstract); Soderlund et al., 1994 (Abstract)). 
These studies showed some degree of performance improvement following Cr supplementation. 
Two other studies have examined the effect of Cr supplementation on relatively long oxygen-
requiring exercise lasting up to a total of 16 minutes (Viru and Nuremviki, 1993) and 24 minutes 
(Balsom et al., 1993b) but no studies have examined the effect of oral Cr supplementation on 
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longer duration endurance exercise such as examined in this study. Viru and Nuremviki (1993) 
found that performance was improved in both 300 m and 1000 m run times as well as in total run 
time of 4 x 300 m and 4 x 100 m. However, Balsom et al., (1993b) showed no improvement in 
performance following Cr supplementation on a 6 km terrain run. We showed no improvement in 
exercise performance lasting one hour. This is unlikely to be due to insensitivity of our exercise 
test, since our laboratory has previously shown a low coefficient of variation for 40 km time-trials 
(coefficient of variation= 1.0 ± 0.5 %,) lasting an average of 56:24 ± 3:59 minutes (Palmer et al., 
1995). 
Nevertheless, despite a lack of effect on performance, this study showed that Cr loading alters 
metabolism during one-hour exercise and recovery following the one-hour cycle. This was shown 
by the changes in indicators of adenine nucleotide metabolism. The indicators of adenine 
nucleotide metabolism examined in this study included plasma ammonia (NH3), hypoxanthine (Hx) 
and urate (Ur) concentrations. Previous studies have shown that plasma NH3 levels are lowered 
during supramaximal exercise when Cr supplemented (Birch et al., 1994; Greenhaff et al., 1993a). 
Another study has shown a lowering of plasma Hx levels during 10 bouts of 6 s short-term high 
intensity exercise (Balsom et al., 1993a), while Balsom et al., (1993b) showed no change in plasma 
Hx levels after Cr supplementation during a 6 km terrain run. In this study, plasma and Hx were 
lowered in the Cr group following supplementation. It should be noted that the plasma levels of 
these two products were elevated (non-significantly) in the Cr group prior to supplementation. 
This is unlikely to be due to diet or training as these were kept consistent from one week to the 
next, and were not elevated to a similar degree following supplementation. 
The purine nucleotide cycle (PNC) is generally believed to operate only under high intensity 
exercise conditions when the balance between ATP supply and ADP phosphorylation is no longer 
possible and there is a continuing high energy demand. Under these circumstances the myosin 
ATPase reaction restores ATP and produces AMP which is immediately deaminated to produce 
IMP and a further series of catabolic reactions ensues. The aim of these reactions is to decrease 
the level of ADP, in order to maintain an optimal ATP:ADP ratio such that contraction can 
continue. A result of this is that adenine nucleotide is lost from the muscle pool. The amount of 
'lost' nucleotide is evidenced in the levels of plasma NH3, Hx and Ur. Each of these metabolites 
indicate the degree to which the PNC has been in operation and they are produced at various 
levels in the PNC. 
30 
It should be noted at this point that protein catabolism is also a source ofNH3 during exercise. 
MacLean et al., (1991) have shown that NH3 production during exercise lasting approimately 100 
minutes is predominantely derived from protein catabolism. However, Lemon and Mullin (1980) 
have previously shown that protein catabolism occurs primarily under conditions where subjects 
are either fasted or carbohydrate (CHO) depleted prior to the exercise tests. In the current study 
the subjects were neither fasted or CHO depleted prior to the exercise, nor did the exercise last up 
to 100 minutes. In addition, the only change between Tl and T2 was an increase in TCr. Thus, 
only the pathway ofNH3 production, affected by the increase in TCr, could possibly have been 
affected. This indicates that even during high-intensity submaximal exercise lasting one hour, a 
significant proportion of NH3 produced is most likely from AMP deamination. 
Thus, Cr loading results in more efficient maintenance of the ATP:ADP ratio with less activation 
of the PNC indicated in the lowering of the plasma NH3 and Hx levels post supplementation. We 
hypothesise that more 'high energy' phosphate may be delivered to the myofibrils through the 'Cr-
PCr shuttle' due to the increased muscle total Cr (TCr) levels after loading. This hypothesis is also 
discussed in studies by Birch et al., (1994); Cooke et al., (1995); Greenhaff et al., (1993a); 
Greenhaff et al., ( 1993b ); Greenhaff et al., ( 1994b ); Greenhaff, ( 1995) and Viru and Nurmeviki, 
( 1993 ). The increase in TCr necessarily increases the amount of PCr, thus increased amounts of 
'high energy' phosphate are available for ADP rephosphorylation. In keeping with increased rates 
of ADP rephosphorylation will be a decrease in the level of AMP and subsequently less IMP ( and 
therefore NH3), less Hx and less Ur. Thus, the increased provision of 'high energy' phosphate 
(from PCr) available for ADP rephosphorylation has probably resulted in the lessening of adenine 
nucleotide degradation seen in this study. This is likely to involve both the mitochondrial and 
myofibrillar sites of the 'Cr-PCr shuttle' since the rephosphorylation of Cr is reliant on ATP 
formed during oxidative processes and occurs at the mitochondrial membrane, and the 
rephosphorylation of ADP is likely to be at the myofibrillar site of utilisation. This is analogous to 
the faster resynthesis rate previously shown at rest during recovery from exhaustive short-term 
high intensity exercise bouts (Greenhaff et al., 1993b; Greenhaff et al., 1994b ). However, we 
provide the first evidence that this is also a significant effect of Cr loading during high intensity 
endurance exercise. 
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It has recently been discovered that successive days of high-intensity training (Hellsten-Westing et 
al., 1993; Stathis et al., 1994) result in prolonged decreases in the resting levels of adenine 
nucleotide in muscle. Although the exercise protocol used in the present study was not similar to 
those high intensity training protocols, it still activated the PNC to a fairly large degree. This is 
evidenced in the plasma NH3, Hx and Ur levels. The improved maintenance of the ATP:ADP ratio 
by the 'Cr-PCr shuttle' rather than through the activation of the PNC ultimately results in 
improved maintenance of intramuscular adenine nucleotides and less subsequent nucleotide 
salvage and less de novo ATP synthesis which is energetically expensive (Tullson and Terjung, 
1991). 
Several studies using supramaximal workloads (Balsom et al., 1993a; Balsom et al., 1993b; Birch 
et al., 1994; Greenhaff et al., 1993a; Soderlund et al., 1994 (Abstract); Stroud et al., 1994) have 
also examined the effect of Cr loading on carbohydrate metabolism by measuring plasma lactate 
levels during exercise. Balsom et al., (1993a) and Soderlund et al., (1994) (Abstract) showing a 
lowering of plasma lactate levels when Cr supplemented, but, other studies (Balsom et al., 1993b; 
Birch et al., 1994; Greenhaff et al., 1993a; Stroud et al., 1994) showing no change in plasma 
lactate levels pre- and post-supplementation. These apparently discrepant results can be explained 
by the different natures of the exercise protocols used. In those cases where the exercise duration 
is sufficiently short that an elevated resting PCr could supply substantial anaerobic energy, plasma 
lactate level is likely to be reduced. However, when the length of the exercise bout is increased 
and the proportion of anaerobic energy supplied by glycolysis overwhelms that supplied by PCr, 
then any effect of Cr supplementation on lactate concentration appears to be negligible. 
The results of this study show that plasma lactate levels were relatively unchanged during a one-
hour distance trial following Cr supplementation and this serves to confirm those results found by 
both Balsom et al., ( 1993b ); Birch et al., ( 1994 ); Greenhaff et al., (1993 a) and Stroud et al., 
(1994). The fact that plasma lactate levels are unchanged implies that there has been no alteration 
in non-oxidative carbohydrate (CHO) metabolism. It is more likely that the degree of activation of 
non-oxidative CHO metabolism is directly related to cycling intensity. This is supported by the 
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unchanged total cycling distance and the similar heart-rate results from Tl to T2. There were also 
no changes after Cr supplementation in exercise intensity at any particular time during the trials. 
The effect of Cr loading on muscle glycogen loading and utilisation was examined in several 
subjects. Cr loading did not significantly affect the degree of muscle glycogen loading and the 
relative utilisation of muscle glycogen was similar between the two trials. The Cr group had higher 
(non-significant) muscle glycogen stores initially but utilised glycogen at a faster absolute rate, 
rendering the relative utilisation rate almost exactly the same. Bosch et al., (1993) have previously 
shown that those individuals with higher muscle glycogen stores use more glycogen during 
endurance exercise. However, the relative amount of muscle glycogen utilised by the 2 groups in 
this trial was similar. These results indicate that a tendancy exists towards Cr supplementation 
increasing muscle glycogen concentration as well as its subsequent absolute utilisation rate. 
Indeed, the results may have been more significant had more subjects consented to a third muscle 
biopsy. 
In the light of these results, it would appear that Cr supplementation has no effect on CHO 
metabolism during one hour of high intensity exercise, a finding that has been described in several 
studies examining maximal exercise. Any effect previously shown is probably the result of the 
duration of the exercise bout. However, the area of Cr supplementation and its effect on muscle 
glycogen concentration and utilisation is one requiring further investigation and therefore this 
discussion does not imply that there was any effect of the Cr supplement. 
The Cr loading regimen described first by Harris et al., (1992) significantly increased intramuscular 
Cr levels by 20 %, however only two subsequent studies have confirmed this finding (Greenhaff et 
al., 1993; Lemon et al., 1995 (Abstract)). In this study, it was found that well-trained endurance 
cyclists increased their intramuscular TCr stores by an average of 36.3 mmol/ kg dry wt or 29 %. 
However, Cr increased significantly in both the placebo and Cr groups in this study. This finding 
may be the result of a delay in freezing times or an artefact of the freezing process (Bangsbo et al., 
1993). Several other studies on Cr loading have not performed muscle biopsies and thus have 
made conclusions about the effect of Cr loading on exercise performance, simply assuming that Cr 
loading had occured (Balsom et al., 1993a; Birch et al., 1994; Earnest et al., 1994 (Abstract); 
Greenhaff et al., 1993a; Viru and Nuremviki, 1993). However, closer examination of the 
33 
individual muscle biopsy results in this study show, like Harris et al., (1992) that there is 
considerable individual variability in the degree to which subjects Cr loaded. This was not related 
to the initial intramuscular TCr concentration (r=0.46, p=0.19). The latter finding is in contrast to 
the finding in Harris et al., (1992) where those individuals with the lowest TCr levels loaded to the 
largest extent. 
Previous studies (summarised by Spriet, 1995) have indicated that the PCr content of Type I fibres 
has been found to be 5 - 15 % lower than in Type Ila and lib. Although this is indicative of either 
a difference in storage capacity or a difference in uptake of Cr under unsupplemented conditions, 
our laboratory hypothesised that individual variation in the uptake or storage capacity ( or both) of 
Cr supplements may also be influenced by fibre type. Myburgh et al., (Med. Sci. Sports Exerc., 
1996 (Abstracts)) have recently shown that fibre type differences influenced Cr uptake with a 
strong positive correlation between percent Type lib and the extent of change in TCr after a 
similar supplementation regimen and in similar calibre endurance-trained athletes (r = 0.95, p < 
0.005) to those used in this study. This implies that Cr uptake may be lower in those athletes more 
suited to endurance activity than in those suited to sprinting ( who characteristically have more 
Type lib fibres). Thus, in this study, it is possible that of the sample of ten cyclists who were 
supplemented with Cr, some tended to be better sprinters or have more Type lib than others, 
explaining the large individual variability in the results. 
It is not known whether this influence of fibre type on Cr uptake following supplementation also 
exists in the more physiological state of lower circulating plasma Cr content. Should this be the 
case, it is possible that endurance trained athletes might have a lower baseline muscle TCr than 
sprinters. A comparison of the baseline data of this study with that of others shows that the mean 
level of TCr was normal. Therefore, I conclude that endurance trained athletes have a normal 
muscle TCr content prior to a Cr supplementation regimen, and elevate it to a similar degree as 
other studies (Harris et al., 1992; Greenhaff et al., 1993; Lemon et al., 1995 (Abstract)) following 
supplementation. 
In this study only one individual responded to Cr loading by increasing intramuscular TCr by less 
than 10 mmol/ kg dry wt. This subject had an initial TCr e,f 108 mmol/ kg dry wt which increased 
to 117 mmol/ kg dry wt following one week of Cr loading. This is only an increase of 8 %. The 
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range of TCr reported in the literature (Harris et al., 1974) is 113.2 - 135.6 mrnol/ kg dry wt. A 
maximal Cr loaded level of 191 mrnol/ kg dry wt was found in one subject in this study which is in 
contrast to Harris et al., (1992) who stated that muscle Cr content appears to have an upper limit 
of 150 - 160 mrnol/ kg dry wt and that this level cannot be exceeded. This result did not appear to 
be due to higher baseline levels which ranged from 108-14 7 mrnol/ kg dry wt. The higher loading 
may be a result of exercising immediately after taking Cr throughout the loading week, a finding of 
Harris et al., (1992) shown in 5 subjects. 
Regression analysis indicated that the degree of Cr loading is fairly well related to the 
improvement in performance (r=0.6, p=0.06), that is, those individuals who increase their TCr the 
most will be those individuals most likely to improve their performance in one hour of high-
intensity cycling. The fact that one subject was a non-responder to Cr loading was examined as a 
possible reason for this close to but non-significant result. A recent study by Lemon et al., (1995) 
(Abstract) also described a non-responder. In this study, the elimination of the non-responder 
from analysis did little to alter the significance of this finding and for this study the Cr group was 
not divided into responders and non-responders. This is probably justified until further 
confirmation and analysis has been performed on prevalence of non-responders. 
Another notable finding was that levels of nucleotide in the rested muscle biopsy samples did not 
change after Cr loading. The levels of nucleotide in resting muscle samples following Cr loading 
has only been reported in one study (Harris et al., 1992). This finding is not surprising given that 
the effect of Cr supplementation is largely related to its effect on the increase in potential energy 
for ATP resynthesis (that is, Cr and PCr) during contraction and it is during contraction and 
resynthesis during recovery that the effect of Cr loading has been reported (Balsom et al., 1993a; 
Birch et al., 1994; Cooke et al., 1995; Greenhaffet al., 1993a; Greenhaffet al., 1993b; Greenhaff 
et al., 1994a; Greenhaff et al., 1994b; Greenhaff, 1995; Viru and Nurmeviki, 1993). 
Thus, while Cr loading may not affect the exercise performance of the type of exercise examined 
in this study, it may be that the cumulative effects of Cr loading and the lowering of the activity of 
the PNC may only become evident later on in exercise, for example, in a two hour exercise test. It 
may be under these circumstances that the effect of improved maintenance of the ATP:ADP ratio 
and less PNC activation and adenine nucleotide loss may result in the cyclist being better able to 
maintain a high exercise intensity over a long exercise duration. Thus, improvements in 
performance may be noted in exercise lasting longer periods of time at similar intensities to those 
examined in this study where the effect oflong-term activation of the PNC and maintainance of 
the ATP:ADP ratio in the face of decreasing adenine nucleotide levels may become relevant in 
terms of the development of fatigue. 
4.3 CONCLUSIONS 
Thus, oral Cr supplementation with 20 g of Cr per day for 7 days did not improve exercise 
performance during a one-hour distance cycle. However, the supplementation regimen increased 
TCr to a similar degree in endurance athletes as that found in previous studies. In addition, CHO 
metabolism was unaltered as evidenced by unchanged plasma lactate levels post-supplementation 
and similar muscle glycogen utilisation rates. However, plasma NH3, Hx and Ur levels were 
lowered post-supplementation. This indicates that Cr supplementation has an effect on adenine 
nucleotide metabolism during a one-hour distance cycle. 
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CHAPTER 5: THESIS CONCLUSIONS 
The ultimate aim of Cr supplementation in athletes is to improve their exercise perfomance. 
However for performance improvement it is necessary for the body to alter its' metabolism or 
muscle function. An alteration in metabolism may result in improved energy production or less of 
an accumulation of fatigue-inducing metabolites or both. From these results it would seem that the 
effect of Cr supplementation during submaximal exercise is most likely an enhancement in PCr 
rephosphorylation and this is manifested as a alteration in adenine nucleotide metabolism and not 
in carbohydrate metabolism. However, any effect on performance was not apparent under the 
circumstances of the exercise tests in this study. It is highly likely that the changes in the metabolic 
variables may only result in an effect on performance as the exercise duration increases whilst 
maintaining a similar exercise intensity. Thus, a one hour cycle may not have been sufficient for the 
improved maintenance of the ATP:ADP ratio and therefore the lowering in adenine nucleotide 
compounds to have an effect on performance. This hypothesis is, in part, based on the slight 
increase in distance covered by the Cr group and the correlation between the change in TCr and 
the change in performance which indicated a tendancy (p=0.06) for peformance to improve the 
more a subject Cr loaded. This may have become significant had the exercise been continued for a 
longer period of time. Thus, a recommendation for future research is to perform a similar trial but 
for one and a half hours at a predetermined exercise intensity followed by a 20 km time trial. 
Alternatively an effect on performance during an exercise protocol such as used in this study may 
only become apparent under other conditions such as elevated temperature or carbohydrate 
depletion where ammonia production is already elevated. 
In conclusion, the major effect of Cr supplementation has been shown to occur during the later 
bouts of intermittent, short duration, high intensity exercise. However, although Cr loading does 
not result in a performance improvement it does alter metabolism during one hour endurance 
exercise. Therefore, the effects of Cr supplementation on performance and metabolism during 
longer duration exercise is an area for future research. 
TABLES 
Table I: Subject characteristics for the placebo (n=lO) and creatine (n=lO) groups. 
Group Age (yrs) Height (m) Mass 1 (kg) Mass 2 (kg) PPO (W) 
Placebo 23.64 ± 1.03 1.78 ± 0.03 74.65 ± 2.46 75.05 ± 2.5* 372.8 ± 13.6 
Creatine 23.58 ± 0.92 1.79 ± 0.02 74.26 ± 2.81 75.08 ± 2.8* 365.8 ± 14.9 
Values are expressed as means ± SEM. Mass 1 = pre-supplementation mass; Mass 2 = 
post-supplementation mass. Statistical analysis by 2-way ANOV A • indicates significant 
difference (p<0.05) from Mass 1. 
Table II: Muscle adenine nucleotide contents (mmol/ kg dry wt) in the placebo (n=IO) 
and creatine (n=IO) group for Tl and T2. 
Group ATP-Tl ATP-T2 ADP-Tl ADP-T2 TNuc-Tl TNuc-T2 
Placebo 22.52±0.7 24.96±1.3 2.63±0.2 2.85±0.3 25.15±0.8 27.81±1.6 
Creatine 23.97±0.7 25.42±1.1 2.68±0.1 2.60±0.2 26.65±0.7 28.02±1.2 
Values are expressed as mean ± SEM. ATP= adenosine triphosphate, ADP= adenosine 
diphosphate, TNuc = Total nucleotide (ATP+ ADP), Tl= pre-supplementation biopsy, 
T2 = post-supplementation biopsy. Statistical analysis by 2-way ANOV A. 
Table ID: Muscle glycogen concentrations (mmol/ kg dry wt) and utilisation (mmol/ kg 
dry wt/ hr) in both the placebo (n=4) and the Cr (n=6) groups pre- and post-
supplementation and post -exercise. 
Group Test 1 Test 2 Post-Test 2 Utilisation % utilised 
Placebo 423 ± 31 407 ± 10 138 ± 11 269 66 % 
Creatine 488 ± 59 554 ± 13 184 ± 6 370 67 % 
V~lues are expressed as means ± SEM. Test 1 = pre-supplementation biopsy, Test 2 = 
post-supplementation biopsy, Post-Test 2 = post-supplementation post-exercise biopsy. 
Statistical analysis by 2-way ANOV A 
FIGURES 
Figure 1: The components of action of the 'Cr-PCr shuttle' and the typical mean Cr and 
PCr concentrations in rested muscle. 
Mitochondria 
low A TP:ADP l 
Cr [ ± 42.6 mmol/ kg dry wt] 
l Contractile Proteins 
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Figure 2: Diagrammatic representation of the pathways of purine nucleotide synthesis 
and degradation. 
Underlined compounds are those markers of adenine nucleotide degradation measures in 
this study during exercise and recovery. 
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Figure 3a: Intramuscular creatine concentration (mean± SEM) in both the placebo 
(n=IO) and creatine (n=:=I 0) groups pre- and post- supplementation. 
b: Intramuscular phosphocreatine concentration (mean± SEM) in both the 
placebo (n=IO) and creatine (n=IO) groups pre- and post- supplementation. 
Clear bar = pre-supplementation, hatched bar= post-supplementation. Statistical analysis 

























Figure 4: Intramuscular total creatine concentration (mean± SEM) in both the placebo 
(n=lO) and creatine (n=lO) groups pre- and post- supplementation. 
Clear bar = pre-supplementation, hatched bar= post-supplementation. Statistical analysis 
by 2-way ANOV A. * indicates significant difference from pre-supplementation (p<0.05). 
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Figure Sa: The relationship between the initial total creatine concentration and the 
change in total creatine concentration in the creatine group (n=lO) (r=0.46, 
p=0.19). 
b: The relationship between the change in total creatine concentration and the 
change in the distance covered in the creatine group (n=lO) (r=0.6, p=0.06). 
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Figure 6a, b, c: Plasma ammonia, hypoxanthine and urate concentrations (mean± SEM) 
in the creatine (n=IO) and (n=l 0) placebo group during exercise (0 to 60 minutes) 
and recovery (up to 70 minutes) pre- and post- supplementation. 
Open symbol = pre-supplementation, filled symbol = post-supplementation. Statistical 
analysis by 3-way ANOV A * indicates significant difference from pre-supplementation 
level and from placebo group and from time O (p<0.05). Plasma urate results for all 
subjects (n=20) shows a significant difference but this is not indicated. 
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Figure 7: Plasma lactate concentration (mean± SEM) in the creatine (n=IO) and placebo 
(n=IO) groups pre- and post- supplementation. 
Open symbol = pre-supplementation, filled symbol = post-supplementation. Statistical 
analysis by 3-way ANOV A Significant time effect from time O not indicated on graph. 
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APPENDIX 1: INFORMED CONSENT FORM 
INFORMED CONSENT 
THE EFFECTS OF CREA TINE SUPPLEMENTATION ON IDGH-INTENSITY 
ENDURANCE PERFORMANCE IN ENDURANCE-TRAINED ATHLETES 
I, (print name please) --------------------
hereby agree to participate in a research project at the MRC/UCT Bioenergetics of 
Exercise Research Unit, University of Cape Town Medical School. 
I understand that this project will involve 4 separate visits to the laboratory separated by 
one week each. The first visit will involve a cycle test to exhaustion with progressively 
increasing workloads ("max test"); the second visit will comprise a familiarisation ride 
on the King Cycle ergometer for 60 minutes, during which time I will cycle at the highest 
intensity which I can sustain for that time using my own bicycle placed on the ergometer. 
I agree to use a back tyre which has never been punctured for all this trial and the 
following two visits. I will receive instructions on how to complete a training and dietary 
intake diary. 
The third visit will comprise a cycle performance test on the King Cycle ergometer in 
which I will cycle at the highest intensity which I can sustain for a period of 1 hour. 
Heart rate, speed and distance will be monitored. During this test blood samples will be 
taken from a catheter inserted into the forearm vein. Approximately 80 ml of blood will 
be taken. Prior to the exercise test, I will have the first muscle biopsy. I understand that 
a muscle biopsy is a minor surgical technique which will be performed by a medical 
doctor experienced in this technique. A local anaesthetic will be administered and the 
procedure will be performed under sterile conditions. As with any surgical technique 
there is a small risk of infection. However, no intramuscular infection has ever been 
described as a complication of a muscle biopsy. In our laboratory over the past 12 years 
we have performed approximately 1000 muscle biopsies. We have had 1 skin infection 
and 1 allergic response to the tape used to cover the incision. 
I will be given tablets to take for the following 7 days. The tablets may be placebo (non-
active agent) or active agent. I agree to take one tablet 4 times per day: three at meal 
times and 1 tablet one hour before a training session. 
The fourth visit to the lab will comprise a pre-exercise biopsy, the same 1 hour distance 
trial followed immediately by a second muscle biopsy. At this time I will hand in my 
training and dietary records. I understand that the code of placebo vs active agent will 
only be broken after all subjects have completed the trial. In addition, no results of 
performance during the distance trial will be made available until all subjects have 
completed the trial. 
I fully understand the risks associated with this project. Furthermore, I understand that I 
am free to withdraw from the study at any time should I so choose. 
Signature ---------
Date ---------- Principal Investigator ---------
APPENDIX 2: INFORMATION SHEET 
THE EFFECTS OF CREATINE SUPPLEMENTATION ON HIGH-INTENSITY ENDURANCE 
PERFORMANCE IN ENDURANCE-TRAINED ATHLETES 
Information sheet 
Summary: This study is a 7-day placebo-controlled double-blind study to determine the effect 
of creatine loading (20g per day) on high intensity endurance performance for 1 hour in 20 well 
trained cyclists. In addition to exercise performance, blood samples and muscle biopsy samples 
will be analysed for serum acid-base balance, lactate, ammonia and hypoxanthine and muscle 
creatine, phosphocreatine, ATP and glycogen contents. A placebo-controlled double-blind 
study is one in which ten subjects receive the active agent (in this case creatine) and 10 receive 
a substitute which looks in all respects similar to the active agent. Neither the subject nor 
investigators are aware of whether the agent is active or placebo until after all analysis is 
completed. 
Protocol: 
Week 1: visit 1 : Standard V02max test; 
visit 2: familiarisation with the King cycle = 1 hour trial; 
training (7-day) and dietary (3-day) record sheets. 
Week 2: pre-exercise muscle biopsy; 
exercise test: 1 hour trial at highest possible intensity 
randomised administration of placebo or active agent (creatine tablets): 4 x 5g/day for 7 
consecutive days; 
repeat and record similar training and diet. 
Week 3: pre-exercise muscle biopsy; exercise test 2; post-exercise muscle biopsy 
Exercise Tests: all to be performed with an unpunctured rear tyre 
* 1 hour distance trial performed with the subjects own bicycle placed on a King Cycle (which 
measures distance achieved; speed and average power output). Blood sampling every 10 min 
for 50 min, then every 5 min for 10 min and during recovery. This is approximately 80 ml. 
*V02 max test performed on a laboratory bicycle starting at an intensity of 3.3 W/kg body 
mass and increased by 50 W for 150 sec and then by 25 W/150 sec. 
Muscle biopsy:Payment:Rl 00 x 3 and RJ 50 bonus on completion of all biopsies. 
A muscle biopsy is a minor surgical technique which will be performed by a medical doctor 
experienced in this technique. A local anaesthetic will be administered by a very small needle. 
The muscle biopsy is performed with a needle which has a 6mm diameter. The needle is 
sterilised at Grootte Schuur hospital and the biopsy is performed under sterile conditions. 
There is a minimal risk of infection. Training will not be affected by the biopsy. 
Tablets: 
You will be given 20 effervecent tablets/day to take for the following 7 days. The tablets may 
be placebo (non-active agent) or active agent. They should be dissolved in luke-warm water or 
tea/coffee. they are tasteless. 5 tablets should be taken at each of 3 meal times and 5 tablets 
one hour before a training session. If you have a rest day, take the fourth batch of tablets 
before bed. 
PROBLEMS: Brett 4394699 
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APPENDIX 5: TABLE OF MEANS± SEM FOR PLASMA NH3, HX AND UR. 
PlasmaNH1 
Group Placebo Crea tine 
Test Test 1 Test 2 Test 1 Test 2 
TimeO 50.6 (4.7) 33.9 (6) 47.3 (5.2) 39.6 (4.5) 
10 71.2 (7.6) 81.5(10) 97 (17.5) 82.4 (8.6) 
20 95 (11.6) 100.1 (14.5) 128 (15.5) 102.3 (9.7) 
40 99.3 (9.5) 114.2 (10.2) 131 (13.6) 102(14.1) 
60 98.4 (18.2) 135.5 (15.5) 145 (14) 105.9 (11.4) 
62 98.4 (6.1) 111.8(15.9) 132.1 (9.6) 106.6 (9.2) 
66 84.3 (7.5) 94.6 (14.8) 113.3 (10.5) 91.8 (8.6) 
70 79.2 (5.7) 85.5 (10.7) 87 (8.2) 69.2 (4.6) 
PlasmaHx 
Group Placebo Creatine 
Test Test 1 Test 2 Test 1 Test 2 
TimeO 1.6 (0.3) 2.3 (0.5) 2.7 (0.8) 2.2 (0.6) 
20 3.4 (0.9) 5.1 (1.3) 10.3 (2.4) 6.2 (1.5) 
40 3.2 (0.7) 3.1 (0.9) 10.6 (2.4) 6.3 (1.6) 
60 3.3 (0.8) 6 (1. 9) 11.7 (2.9) 5.2(1.7) 
62 4.7(1.1) 8.7 (2.9) 15.6 (3.7) 6.8 (1.6) 
66 7.5 (1.4) 12.1 (3.1) 16.7 (3.6) 11.2(1.8) 
70 9.2 (2.1) 10.1 (3.3) 15.9 (3.6) 12.1 (2.4) 
Plasma Ur 
Group Placebo Creatine 
Test Test 1 Test 2 Test 1 Test 2 
TimeO 314.9 (22.2) 303 (22.5) 318.9 (12) 271.8 (13.1) 
20 318.1 (16.1) 305.8 (19.8) 339.9 (13.3) 288.5 15.2) 
40 333.5 (21.2) 301.5 (17.4) 340.5 (16) 302.2 (14.4) 
60 354.5 (15.3) 317.1 (20.2) 353.1 (15.2) 295.2 (13.5) 
62 337.8 (14.2) 320.3 (19) 359.4 (12.3) 298.7 (13.6) 
66 348.6 (22.5) 320.3 ( 17.8) 351.9 (15.5) 303 (13.7) 
70 345 (22.7) 324.9 (24.4) 356.3 (14.2) 306.9 (16) 
